We did it!!! Groundbreaking news: Tidepool Loop receives FDA Clearance! This is the first ever fully interoperable automated insulin dosing app, cleared by the FDA that began as a patient-led initiative. Find the inside scoop here: tidepool.org/tidepool-loop

More evidence that Automated Insulin Delivery is the gold standard for those struggling with the burdens of diabetes - Impact of Advanced Hybrid Closed Loop on Youth With High-Risk Type 1 Diabetes Using Multiple Daily Injections diabetesjournals.org/care/article-a… Edgar Diabetes & Obesity Research Dr Martin de Bock

When a highly educated HCP uses a “belief” to not use evidence base. 🤯. Deep breath, everyone learns at a different pace. Onwards. #calmingdownnow.

Edgar Diabetes & Obesity Research Dr Martin de Bock Diabetes Youth NZ - New study recruiting soon - World-first trial helping type 1 diabetes described as huge success 1news.co.nz/2023/02/08/wor…

Want to learn more? I summarized the continuation results (bit.ly/3S8Qh9u) plus the original 24 week RCT results in NEJM (bit.ly/3AWqlqf). DOI to continuation results: doi.org/10.1089/dia.20… PS - Author copies are available at DIYPS.org/research!

Hot off the press - Fantastic news for CGM funding - finally feels like progress being made! Thanks to all those who have been advocating. Edgar Diabetes & Obesity Research Dr Martin de Bock Hamish Crocket

Time to advocate CGM in T2D, looking forward to great sessions today #ATTD2023

Goran Petrovski presents data on starting paediatric pwt1d onto AID from MDI. 10 day initiation protocol, CGM, then CSII, then HCL. TIR hits 70% and maintained out to 12 months. DTSQ showed high satisfaction. #ATTD2023

Showtime #ATTD23

Dr Martin de Bock begins by highlighting T2D has had less focus for diabetes tech research. Notes despite this lack of focus, existing trials show similar results to T1D trials. Shows cases of participants with life changing improvements from CGM including cessation of... 1/2

Boris kovatchev, legend, reminding us of the challenging physiological milieu to be overcome when attempting fully closed loop. #ATTD23

JUGAAD, I learned a new word today - the Indian way of improvising and frugal innovation. #ATTD2023

How far are we from fully closed loop? News from #ATTD2023, covering clinical trials, real world experience and as much research as we can fit. #ATTD23 #DEDocVoices diabettech.com/automated-insu…

ICYMI: “Advanced automated insulin delivery for these young people struggling with their #diabetes management was life-changing for many." Dr Ben Wheeler Edgar Diabetes & Obesity Research Dr Martin de Bock bit.ly/3ze3iXC

AID trial: 2.0: 9news.com.au/national/artif…

Awesome to be collaborating with the Baker Institute, using open source to fully close the loop. ⁦OpenAPS.org⁩ ⁦Dana M. Lewis | #OpenAPS 🤖⁩ ⁦@JDRF⁩ 9news.com.au/national/artif…

A history lesson needed, and more stigma for T2DM. Caduceus, a bad error became a symbol in medicine (the patron of thieves). Asclepius is the one with single snake - from the god of healing. It’s the small things..

Are we Following in Banting’s footsteps or straying from the path? You decide, from what we observed. frontiersin.org/articles/10.33…

NZ announces free CGM and pumps for all NZers with T1d. Huge moment for our small nation. Limited choice, but we’ll take it! AID for all!

At ATTD Neale Cohen (CoPI Martin deBock) presented CLOSE IT trial: Full vs Hybrid Closed Loop (Ypsomed Oref Novorapid) system in adults with T1D. Non-inferiority primary endpoint met. 🎉Well done all participants. Thanks sponsors (breakthrough t1D + NZ Council). Guides next step